Remeron and Vasculitis - a phase IV clinical study of FDA data

Summary:

Vasculitis is reported as a side effect among people who take Remeron (mirtazapine), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Vioxx, and have Hepatitis c.

The phase IV clinical study analyzes which people have Vasculitis when taking Remeron. It is created by eHealthMe based on reports of 24,977 people who have side effects when taking Remeron from the FDA, and is updated regularly.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.

What is Vasculitis?

Vasculitis (inflammation of a blood vessel or blood vessels) is found to be associated with 968 drugs and 1,214 conditions by eHealthMe. Check the latest studies of Vasculitis.

On Jul, 27, 2026

24,977 people reported to have side effects when taking Remeron.
Among them, 20 people (0.08%) have Vasculitis.

Among these 20 people:

How long have people been on Remeron when they have Vasculitis? *

What is the gender of people who have Vasculitis when taking Remeron? *

female: 80 %
male: 20 %

What is the age of people who have Vasculitis when taking Remeron? *

What are other drugs people take besides Remeron? *

What are other side effects people have besides Vasculitis? *

Weakness: 12 people, 60.00%
Pain: 10 people, 50.00%
Chest Pain: 10 people, 50.00%
Diplopia (double vision): 9 people, 45.00%
Connective Tissue Disorder (any disease that has the connective tissues of the body): 8 people, 40.00%
Fall: 8 people, 40.00%
Indigestion: 8 people, 40.00%
Joint Crepitation: 8 people, 40.00%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 8 people, 40.00%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 8 people, 40.00%

What are the existing conditions these people have? *

Hepatitis C: 8 people, 40.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 10.00%
Type 2 Diabetes: 1 person, 5.00%
Sleep Disorder: 1 person, 5.00%
Pain: 1 person, 5.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.00%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
High Blood Cholesterol: 1 person, 5.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 5.00%
Blood Uric Acid Increased: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Remeron and have Vasculitis?

- Check whether Vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remeron:

Remeron (26,474 reports)

Vasculitis treatments and more:

Vasculitis (18,555 reports)

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vasculitis:

Vasculitis (968 drugs)

Browse all the conditions that are associated with Vasculitis:

Vasculitis (1,214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirtazapine (the active ingredients of Remeron) and Remeron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.